|
WO2020187848A1
|
|
Lnterleukin-2 receptor (il2r) and interleukin-2 (il2) variants for specific activation of immune effector cells
|
|
WO2020161224A1
|
|
Treatment involving car-engineered t cells and cytokines
|
|
WO2020161186A1
|
|
Chimeric antigen receptor-modified cells for the treatment of cldn6-expressing cancers
|
|
AU2018333530A1
|
|
RNA replicon for expressing a T cell receptor or an artificial T cell receptor
|
|
WO2018166589A1
|
|
Antigen receptors and uses thereof
|
|
WO2017059900A1
|
|
Antigen receptors and uses thereof
|
|
WO2016180467A1
|
|
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
|
|
WO2016180468A1
|
|
Claudin-18.2-specific immunoreceptors and t cell epitopes
|
|
AU2015239683A1
|
|
Claudin-6-Specific immunoreceptors and T cell epitopes
|
|
ME02810B
|
|
Antigen-specific t cell receptors and t cell epitopes
|
